Dr. Eileen O’Meara practices cardiology at the Montreal Heart Institute/Université de Montréal. She completed a Fellowship in Heart Failure, and another in Stress Echocardiography and Tissue Doppler. She is a member of the Research Core Echo Laboratory at MHI, member of the teaching Committee at UdeM for Multisystem Diseases, member of the Internal Review Board at the MHI and Chief of Outpatients Clinics at MHI. She served as Co-Chair of the Primary Panel for the Canadian Cardiovascular Society and Canadian Heart Failure Society HF Guidelines (CCS and CHFS, 2016-2019) and as co-chair of the Cardiorenal Protection Guidelines for the CCS/CHFS (2020-2022). She is co-director of the Myocardial Axis team for HF research at MHI (2022-present). Her research focuses on remodeling and fibrosis in HF, including cardiac imaging biomarkers; as well as on comorbid conditions that contribute to HF, more specifically diabetes, CKD and anemia. She has been involved in several large HF trials as a NLI or as a SC member. She currently holds the Carolyn et Richard J. Renaud Research Chair in Heart Failure at the Montreal Heart Institute.